These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

597 related items for PubMed ID: 6197099

  • 1. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state.
    Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S.
    Biol Psychiatry; 1983 Oct; 18(10):1141-52. PubMed ID: 6197099
    [Abstract] [Full Text] [Related]

  • 2. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M.
    Med Biol; 1985 Oct; 63(1):1-17. PubMed ID: 2582215
    [Abstract] [Full Text] [Related]

  • 3. Age effect on dopamine and serotonin metabolite levels in cerebrospinal fluid.
    Seifert WE, Foxx JL, Butler IJ.
    Ann Neurol; 1980 Jul; 8(1):38-42. PubMed ID: 6157351
    [Abstract] [Full Text] [Related]

  • 4. Stability of monoamine metabolites in human cerebrospinal fluid.
    Langlais PJ, Bird ED, McEntee WJ.
    Ann Neurol; 1982 Jul; 12(1):48-51. PubMed ID: 6180677
    [Abstract] [Full Text] [Related]

  • 5. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection].
    Yoshino K.
    No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264
    [Abstract] [Full Text] [Related]

  • 6. [Biochemical studies in delirium tremens (author's transl)].
    Athen D, Beckmann H, Ackenheil M, Markianos E.
    Arzneimittelforschung; 1978 Nov; 28(9):1527-8. PubMed ID: 582551
    [Abstract] [Full Text] [Related]

  • 7. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system.
    González-Quevedo A, García JC, Fernández R, Fernández Cartaya L.
    Bol Estud Med Biol; 1993 Nov; 41(1-4):13-9. PubMed ID: 7521168
    [Abstract] [Full Text] [Related]

  • 8. Reduced concentrations of arginine vasopressin and MHPG in lumbar CSF of patients with Korsakoff's psychosis.
    Mair RG, Langlais PJ, Mazurek MF, Beal MF, Martin JB, McEntee WJ.
    Life Sci; 1986 Jun 23; 38(25):2301-6. PubMed ID: 2425205
    [Abstract] [Full Text] [Related]

  • 9. [Clinical course and CSF monoamine metabolism in neuroleptic malignant syndrome--a study of nine typical cases and five mild cases].
    Nishijima K, Ishiguro T.
    Seishin Shinkeigaku Zasshi; 1989 Jun 23; 91(6):429-56. PubMed ID: 2479043
    [Abstract] [Full Text] [Related]

  • 10. Monoamine metabolites in the CSF of epileptic patients.
    Laxer KD, Sourkes TL, Fang TY, Young SN, Gauthier SG, Missala K.
    Neurology; 1979 Aug 23; 29(8):1157-61. PubMed ID: 37460
    [Abstract] [Full Text] [Related]

  • 11. Cerebrospinal fluid neurotransmitter metabolites in neurologically normal infants and children.
    Langlais PJ, Walsh FX, Bird ED, Levy HL.
    Pediatrics; 1985 Mar 23; 75(3):580-6. PubMed ID: 2579365
    [Abstract] [Full Text] [Related]

  • 12. CSF monoamine metabolites in mania.
    Swann AC, Secunda S, Davis JM, Robins E, Hanin I, Koslow SH, Maas JW.
    Am J Psychiatry; 1983 Apr 23; 140(4):396-400. PubMed ID: 6188381
    [Abstract] [Full Text] [Related]

  • 13. Monoamine metabolites in successive samples of spinal fluid. A comparison between healthy volunteers and patients with multiple sclerosis.
    Andersen O, Johansson BB, Svennerholm L.
    Acta Neurol Scand; 1981 Apr 23; 63(4):247-54. PubMed ID: 6163303
    [Abstract] [Full Text] [Related]

  • 14. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
    Petrakis IL, Trevisan L, D'Souza C, Gil R, Krasnicki S, Webb E, Heninger G, Cooney N, Krystal JH.
    Alcohol Clin Exp Res; 1999 Aug 23; 23(8):1336-41. PubMed ID: 10470976
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.
    Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR.
    Ann Neurol; 1987 Apr 23; 21(4):408-11. PubMed ID: 2437853
    [Abstract] [Full Text] [Related]

  • 16. Concentration gradients of monoamine metabolites in human cerebrospinal fluid.
    Sjöström R, Ekstedt J, Anggård E.
    J Neurol Neurosurg Psychiatry; 1975 Jul 23; 38(7):666-8. PubMed ID: 1159438
    [Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid amine metabolites in delirium tremens.
    Banki CM, Molnar G.
    Psychiatr Clin (Basel); 1981 Jul 23; 14(3):167-77. PubMed ID: 6173895
    [Abstract] [Full Text] [Related]

  • 18. Monoamine metabolites in cerebrospinal fluid during acute cerebral ischemia.
    Tang HZ, Lu XF, Wang KJ, Ou YS, Huang YQ.
    Chin Med J (Engl); 1989 Jan 23; 102(1):18-23. PubMed ID: 2475306
    [Abstract] [Full Text] [Related]

  • 19. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May 23; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 20. 3-methoxy-4-hydroxyphenylglycol, 5-hydroxyindoleacetic acid, and homovanillic acid in human cerebrospinal fluid. Storage and measurement by reversed-phase high-performance liquid chromatography and coulometric detection using 3-methoxy-4-hydroxyphenyllactic acid as an internal standard.
    Javors MA, Bowden CL, Maas JW.
    J Chromatogr; 1984 Dec 12; 336(2):259-69. PubMed ID: 6085084
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.